Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate
Apply Filters

Clinical Trials

Index=alz-completesite

Don’t just hope for a cure, help us find one. Participating in a clinical trial, whether you’re living with the disease or not, can make a big difference.

Why Participate in a Clinical Trial?

Index=alz-completesite

Clinical trials provide many participants access to cutting-edge treatments and expert medical care. And someday, they will lead us to the end of Alzheimer’s.

AAIC Advancements: Immunity

Index=alz-completesite

Join us in Boston and online for the latest research and clinical trial findings about the roles of innate and adaptive immunity in Alzheimer’s and dementia.

TrialMatch: Find Clinical Trials for Alzheimer's and Other Dementia

Index=alz-completesite

Help advance Alzheimer's research using our free TrialMatch matching tool.

Addressing Diversity in Alzheimer’s Clinical Trials

Index=alz-completesite

The National Institute on Aging (NIA) launches a website for creating customizable recruiting materials for communities of color, as reported at AAIC 2021.

Clinical Trials

Index=alz-completesite

Don’t just hope for a cure, help us find one. Participating in a clinical trial, whether you’re living with the disease or not, can make a big difference.

Clinical Trials

Index=alz-completesite

Don’t just hope for a cure, help us find one. Participating in a clinical trial, whether you’re living with the disease or not, can make a big difference.

17 Recommendations for Researchers to Better Communicate with Study Participants When Trials End Early

Index=alz-completesite

New recommendations for clinical trial sponsors & dementia researchers provide guidance to better communicate with participants when studies end early.

Alzheimer's Association Statement on Gantenerumab Phase 3 Topline Data Release

Index=alz-completesite

The Alzheimer’s Association is disappointed by the topline Phase 3 data reported today by Genentech and Roche from the Phase 3 clinical trials of gantenerumab.

DIAN-TU Phase 3 Clinical Trials, Topline Results

Index=alz-completesite

Neither gantenerumab or solanezumab met its primary outcome, which was a slowing of cognitive decline as measured by multiple tests of thinking and memory.

Alzheimer’s Association Webinar to Highlight Importance of Clinical Trials and Research in the Black Community

Index=alz-completesite

Black History Month event brings together leaders to discuss strategies for engaging Black Americans in Alzheimer’s and dementia research and clinical trials.

The Equity in Neuroscience and Alzheimer’s Clinical Trials (ENACT) Act Introduced in Congress

Index=alz-completesite

Bipartisan Legislation to Support Equity in Alzheimer’s Clinical Trials Endorsed by Alzheimer’s Association, Alzheimer’s Impact Movement

Ten Ways to Increase Latino Participation in Alzheimer’s Research from Leaders in Health Equity Science

Index=alz-completesite

Leaders in health equity have issued an urgent call to address the underrepresentation of U.S. Latinos in Alzheimer's and dementia clinical trials.

Biogen, Eisai Stop Phase 3 Trials of Aducanumab in Alzheimer’s Disease

Index=alz-completesite

Analysis Conducted by Independent Data Monitoring Committee Indicated 2 Phase 3 Trials of Aducanumab Unlikely to Be Successful

Eisai, Biogen Stop Phase III Trials of Elenbecestat in Mild Alzheimer’s Disease

Index=alz-completesite

Phase III Studies of Elenbecestat in People With Early Alzheimer's Had Safety Issues, Causing Eisai and Biogen to Discontinue Clinical Trials

Alzheimer’s Association Statement on New Clinical Trial Results Reported at AAIC 2022

Index=alz-completesite

The results of several clinical trials exploring both drug and non-drug strategies to address Alzheimer's disease & dementia were reported at AAIC 2022.

Alzheimer's Association Part The Cloud Grant Program-Funded Projects Reach $1 Billion in Follow-On Funding

Index=alz-completesite

Plus, Part the Cloud awards $4.75 million to six new, innovative clinical trials

Alzheimer’s Association Makes Bold Investment in Venture Capital Fund to Accelerate Development of New Treatments

Index=alz-completesite

The Alzheimer’s Association commits $10.85 million to a venture capital fund that invests in companies developing promising treatments for Alzheimer’s.

Alzheimer's Association Commits $14 Million to Novel Drug Trials in Rare Form of Alzheimer's

Index=alz-completesite

Funding will help expand the Dominantly Inherited Alzheimer’s Network Trials Unit to include anti-tau drugs

Alzheimer’s Association Statement Phase III Results for Tarenflurbil (Flurizan)

Index=alz-completesite

Alzheimer News 6/30/2008 | Alzheimer's Association

Alzheimer's Association Statement on Topline Results of the A4 Trial of Solanezumab

Index=alz-completesite

The Alzheimer’s Association is disappointed by the topline results from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) Study of solanezumab.

Alzheimer's Association Welcomes Revised Label for Aduhelm

Index=alz-completesite

The Alzheimer’s Association is pleased with the announcement today that the FDA has revised the prescribing label for Aduhelm™ (aducanumab).

Alzheimer’s Association Chief Science Officer Maria Carrillo Awarded Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research

Index=alz-completesite

The Alzheimer’s Association celebrates Maria C. Carrillo, Ph.D., chief science officer, Alzheimer’s Association, for receiving the Lifetime Achievement Award

Critical Alzheimer’s and Dementia Priorities Signed Into Law

Index=alz-completesite

The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) commend the passage of the fiscal year 23 (FY23) budget

Experts Reframe “Clinical Meaningfulness” in Alzheimer's

Index=alz-completesite

An expert work group has developed an improved definition of clinical meaningfulness in Alzheimer's.

Alzheimer's Association Part The Cloud Grant Program Invests $24 Million in 16 Innovative Research Trials

Index=alz-completesite

Global research program provides strategic funding to fuel Alzheimer’s and dementia science and accelerate treatment

Alzheimer's Association Announces National Effort to Collect "Real World" Data on Newly-Approved Treatments

Index=alz-completesite

The Alzheimer's Association, along with other clinical research experts, announced The National Treatment and Diagnostic Alzheimer's Registry.

Alzheimer’s Association Statement on Lecanemab Phase 3 Topline Data Release

Index=alz-completesite

The Alzheimer’s Association enthusiastically welcomes the positive topline data reported today by Eisai and Biogen

Surprising Differences Found in How Sleep Medications Increase Dementia Risk for Some, Protect Others

Index=alz-completesite

Plus, Two Treatment Trials Tackle Sleep Problems in People With Dementia

Alzheimer's Association statement on semagacestat trial

Index=alz-completesite

August 17, 2010 | Alzheimer's Association

Alzheimer's Association statement on solanezumab Phase 3 results

Index=alz-completesite

Alzheimer's News 8/24/2012 | Alzheimer's Association

Alzheimer’s Association Says CMS Draft Decision to Cover PET Imaging for Alzheimer’s Disease Will Enable Timely Diagnosis

Index=alz-completesite

The Alzheimer’s Association commends CMS for taking action to expand coverage of brain amyloid PET imaging for the diagnosis of Alzheimer’s disease.

Alzheimer’s Association Awards Longeveron $3 Million Grant for Innovative Clinical Trial

Index=alz-completesite

Significant Part the Cloud Research Funding to Examine Adult Stem Cells and Neuroinflammation

Alzheimer’s Association Disappointed by Medicare Coverage Policy for FDA-Approved Alzheimer’s Disease Treatments

Index=alz-completesite

CMS has created unnecessary barriers for individuals with Alzheimer’s disease.

2nd Annual Black Men’s Brain Health Conference Examines Black Men’s Higher Risk for Alzheimer’s, Dementia and Other Brain Disorders

Index=alz-completesite

Leading researchers and community leaders convene in Tempe, Ariz. on February 8-9

Alzheimer’s Association Releases Inaugural DEI Report

Index=alz-completesite

New report highlights the Association’s wide-ranging work in engaging diverse communities in reducing health disparities and achieving health equity.

Biogen to Submit Aducanumab Results in Early Alzheimer’s to FDA

Index=alz-completesite

Alzheimer’s Association Encouraged to Learn Biogen Pursuing Regulatory Approval

Alzheimer’s Association Takes On Leadership Role In Landmark Alzheimer’s Biomarker Study — Known As ADNI4 — To Convene Private Partner Scientific Board

Index=alz-completesite

The Alzheimer's Association will convene the Private Partner Scientific Board (PPSB) of the extension of ADNI4.

Alzheimer’s Association Announces Milestone of $100 Million Invested in Research in 2023

Index=alz-completesite

This unparalleled commitment stands as the largest single-year investment since the organization’s founding in 1980.

Congress Prioritizes Addressing Alzheimer’s and Dementia

Index=alz-completesite

Key provisions of ENACT Act, strengthened FDA accelerated approval pathway, $226 million increase for research, $33 million to fund Alzheimer’s public health.

Six Essential Terms Every Alzheimer’s and Dementia Caregiver Needs to Know

Index=alz-completesite

Alzheimer’s Association offers guidance to America’s 11 million Alzheimer’s caregivers

Alzheimer’s Diagnosis, Management Improved by Brain Scans

Index=alz-completesite

First Phase of Nationwide Study Demonstrates Clinical Impact of Amyloid PET Imaging

Outlooks with Garrett Davis

Index=alz-completesite

Award-Winning Playwright Raises Awareness with New Production

Alzheimer’s Association Statement on CMS Draft Decision

Index=alz-completesite

Today’s draft decision by the Centers for Medicare & Medicaid Services (CMS) is shocking discrimination against everyone with Alzheimer’s disease.

Unlocking the Christchurch Variant

Index=alz-completesite

Rare Gene Variant Could Lead to New Alzheimer’s Treatments

New Alzheimer’s Association Report Finds Doctors and the Public Face Challenges in Understanding and Distinguishing Early Alzheimer’s Development from 'Normal Aging'

Index=alz-completesite

2022 Facts and Figures report covers the latest Alzheimer's data, and the need to increase public and physician awareness of mild cognitive impairment (MCI).

New Alzheimer’s Association Report Examines Racial and Ethnic Attitudes on Alzheimer’s and Dementia Care

Index=alz-completesite

Annual report shows more than 6 million Americans are living with Alzheimer’s

Alzheimer's Association Commits $14 Million to Prevention Trial in Rare Alzheimer's

Index=alz-completesite

The Alzheimer’s Association®, with the GHR Foundation and Edward Jones, announced a $14 million commitment

The Alzheimer's Association and Part the Cloud Honored for Best Health Fundraising Event in the 2nd Annual Anthem Awards

Index=alz-completesite

Part the Cloud, in partnership with the Alzheimer’s Association, was announced today as Best Health Fundraising Event in the 2nd Annual Anthem Awards.

Researchers Add HIV/AIDS, Diabetes and Organ Transplant Drugs to the Medley of Approaches for Treating Alzheimer's Disease

Index=alz-completesite

Alzheimer’s Association Part the Cloud Program Takes the Field a Step Closer to Effective Therapy With Five New Grants

Advisory Council on Alzheimer's Research, Care and Services holds first meeting

Index=alz-completesite

Alzheimer's News 09/27/11 | Alzheimer's Association

Panel requires additional data about brain amyloid imaging for Alzheimer's disease

Index=alz-completesite

Alzheimer's News 1/30/2013 | Alzheimer's Association

Scientific Community: New Alzheimer’s Treatment Most Appropriate for Early-Stage, MCI

Index=alz-completesite

Leading voices in the Alzheimer’s and dementia scientific community underscored that Aduhelm™ (aducanumab) be made available to the population who may benefit.

Silicon Valley Leaders Join Forces for Alzheimer's Association Part the Cloud Gala

Index=alz-completesite

Tech titans, business leaders, and celebrities raise millions of dollars, and awareness, for critical Alzheimer’s research

Alzheimer’s disease supersedes diabetes as sixth leading cause of death in the United States

Index=alz-completesite

Alzheimer News 6/12/2008 | Alzheimer's Association

Legislation reintroduced to improve diagnosis of Alzheimer's and strengthen care planning

Index=alz-completesite

Alzheimer's News 4/11/2013 | Alzheimer's Association

Alzheimer’s Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer’s Disease

Index=alz-completesite

We welcome today’s announcement of a National Coverage Determination (NCD) analysis, consistent with the Alzheimer’s Association position.

Alzheimer’s Association Launches New Health Systems Initiative

Index=alz-completesite

Effort Seeks to Help Health Systems Improve Health Outcomes

Association to continue to advocate for coverage of diagnostic tool

Index=alz-completesite

Alzheimer's News 7/5/2013 | Alzheimer's Association

Alzheimer's Association Doubles Investment to $60 Million for Part the Cloud Grant Program

Index=alz-completesite

Bill Gates Funds $10 Million Grant in Match Challenge to Fuel Research and Accelerate Alzheimer’s Treatment

Alzheimer’s Association Welcomes U.S. FDA Traditional Approval of Leqembi: Full Details

Index=alz-completesite

UPDATED: The Alzheimer’s Association celebrates the FDA action to grant traditional approval to Leqembi (lecanemab) for the treatment of early Alzheimer’s.

Alzheimer’s Association Applauds CMS Decision to Cover PET Imaging for Alzheimer’s Disease Diagnosis

Index=alz-completesite

A valuable Alzheimer’s disease diagnostic tool, PET scans, will now be more accessible across the country thanks to today's Medicare & Medicaid policy change.

World Alzheimer Report confirms interventions for people with mild dementia beneficial

Index=alz-completesite

Alzheimer's News 9/14/2011 | Alzheimer's Association

Partnership Awards $3 Million in Grants for Promising New Treatments in Alzheimer's, Related Dementias

Index=alz-completesite

Alzheimer’s Association, Rainwater Charitable Foundation Join Forces

Nearly $4 Million in Research Funding for Promising New Treatments in Alzheimer's and Other Dementia

Index=alz-completesite

Alzheimer’s Association and Rainwater Charitable Foundation continue efforts to accelerate drug discovery

Daily Multivitamin Slows Cognitive Aging in Three-Year Study Published in Alzheimer’s & Dementia

Index=alz-completesite

Results from the COSMOS-Mind study of more than 2,200 older adults found that taking a daily multivitamin-mineral supplement resulted in a cognitive benefit.

Cannabis: Helpful or Harmful?

Index=alz-completesite

Researchers Call for Caution

Alzheimer's Disease: Early Detection Matters wins American Express Members Project

Index=alz-completesite

October 14, 2008 | Alzheimer's Association

Alzheimer's Association statement regarding biomarkers article in Archives of Neurology

Index=alz-completesite

Alzheimer News 8/11/2010 | Alzheimer's Association

Alzheimer’s Association Funds 2-Year Extension of SPRINT MIND Study

Index=alz-completesite

SPRINT MIND 2.0 to Clarify Role of Intensive Blood Pressure Lowering in Reducing Dementia Risk

Gdavis Productions and Alzheimer's Association Bring "Unforgettable" to Los Angeles

Index=alz-completesite

Production aims to reduce Alzheimer’s disease stigma, educate and entertain underserved communities

Part the Cloud Luncheon Highlights a Decade of Progress in Alzheimer’s and Dementia Research; Celebrates $67 Million Raised and $1.2 Billion in Follow-On Funding

Index=alz-completesite

More than 200 attendees gathered to hear from leading Alzheimer’s experts about how Part the Cloud propels progress in dementia research.

Groups unite to cross lines between Alzheimer's and Parkinson's

Index=alz-completesite

Alzheimer's News 2/5/2014 | Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association Announces New Editor-In-Chief

Index=alz-completesite

The Alzheimer’s Association welcomes Donna M. Wilcock, Ph.D., as the new Editor-in-Chief of Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association

Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release

Index=alz-completesite

The Alzheimer's Association welcomes the positive data on the Phase 3 clinical trial of donanemab for treatment of early symptomatic Alzheimer's disease.

New Alzheimer’s Association Report Finds Patient-Physician Communication About Cognitive Concerns Needs Improvement as New Treatments Become Available

Index=alz-completesite

The 2023 Facts and Figures report examines patients' and doctors' reluctance to address memory concerns, which hinders diagnosis and access to new treatments.

Alzheimer’s Association and the NFL Alumni Association Announce New Partnership to Raise Awareness of Alzheimer’s Disease and Other Dementia

Index=alz-completesite

The Alzheimer’s Association and the NFL Alumni Association (NFLA) announced a new partnership today.

Bipartisan Improving HOPE for Alzheimer's Act Introduced in Senate, House

Index=alz-completesite

Legislation to Educate Clinicians on Care Planning Services Available Through Medicare

"Unforgettable" Stage Play Set for 10 U.S. Cities in 2024

Index=alz-completesite

The Alzheimer’s Association and Gdavis Productions team up to shed light on the importance of early detection of Alzheimer’s and reducing health disparities.

Alzheimer's Association commends recognition of Alzheimer's and dementia as global health threat

Index=alz-completesite

Alzheimer's News 4/11/2012 | Alzheimer's Association

New statement to medical community demands a dignified diagnosis of dementia

Index=alz-completesite

New statement to medical community demands a dignified diagnosis of dementia | Alzheimer's Association

Alzheimer’s Association Zenith Fellows Awards Pursue Novel Treatments and Protection Gene for Alzheimer’s Disease

Index=alz-completesite

Grants Support New Approaches to Treatment of Alzheimer’s and Other Dementias

Alzheimer’s Association Funds Expansion of Cognition Study in World’s Longest Running Birth Cohort

Index=alz-completesite

The Alzheimer’s Association and University College London (UCL) are partnering to study brain aging and dementia

Congressional Leaders Advance $300 Million Alzheimer’s Research Funding Increase, Improving HOPE for Alzheimer’s Act and Renew Investment in Alzheimer’s Public Health In Omnibus Bill

Index=alz-completesite

The Alzheimer’s Association and Alzheimer’s Impact Movement (AIM) commend Congressional leaders for today’s decision to advance a series of bipartisan policies

Federal Alzheimer's and Dementia Research Funding Reaches $3.1 Billion Annually

Index=alz-completesite

Improving HOPE for Alzheimer’s Act, Funding for BOLD Infrastructure for Alzheimer’s Act Signed Into Law

Alzheimer’s Association Announces New Partnership with 100 Black Men of America, Inc.

Index=alz-completesite

New partnership announced to support Black Americans living with Alzheimer’s disease and other dementias and their caregivers.

Alzheimer’s Association Names Dr. Joanne Pike its Next Chief Executive Officer

Index=alz-completesite

Appointment of public health veteran and current Association president signals continued focus on scientific progress and access for treatments

Dr. Joanne Pike Assumes Role of Alzheimer’s Association Chief Executive Officer

Index=alz-completesite

Public health veteran and Association president signals continued focus on scientific progress and access for treatments for all who will benefit

The Alzheimer’s Association and MATTER Select Neurotrack as Winner of Pitch Competition

Index=alz-completesite

The Alzheimer’s Association and MATTER selected the winner and runners up in the competition to develop new tools for early assessment of Alzheimer's.

Broad Bipartisan Support for Access to FDA-Approved Alzheimer’s Treatments on Full Display During Senate Budget Hearings

Index=alz-completesite

Alzheimer’s Association advocates flood Senate budget hearings to push HHS secretary to cover Alzheimer’s treatments.

The Ad Council and Alzheimer’s Association Promote Importance of Early Detection of Alzheimer’s in Touching New Campaign Featuring NASCAR Driver Ryan Blaney

Index=alz-completesite

New PSAs from the Ad Council, Alzheimer’s Association and NASCAR encourage families to talk about seeing a doctor together at the first signs of dementia.

Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means

Index=alz-completesite

Tony Gonzales testified before the House Ways and Means Health Subcommittee on what access to treatments would mean for the Alzheimer’s community.

Alzheimer’s Association to Host Rallies in All 50 States to Make New Treatments for Alzheimer’s Accessible

Index=alz-completesite

During Alzheimer’s & Brain Awareness Month, the Association is ramping up its efforts to make FDA-approved treatments for early-stage Alzheimer's accessible.

Alzheimer’s Association and The Links, Incorporated Announce Partnership

Index=alz-completesite

Together, the Alzheimer’s Association and The Links, Incorporated, will provide Alzheimer’s disease information and resources to Black American communities.

Bonus Shot

Index=alz-completesite

New Studies Show Some Vaccines May Lower Alzheimer’s Risk

Alzheimer's Association statement on screening for cognitive impairment in older adults

Index=alz-completesite

Alzheimer's News, 10/21/2013 | Alzheimer's Association

Alzheimer’s Association Part the Cloud Gala Raises More Than $33 Million

Index=alz-completesite

Business leaders, tech titans, professional athletes, and philanthropists came together to raise awareness and money for Alzheimer’s research.

Alzheimer’s Association Welcomes Announcement of CMS Coverage for FDA-approved Treatments

Index=alz-completesite

The Association will work with payers & health systems to deliver broad access, calling on CMS to open reconsideration of its National Coverage Determination.

Olympians United Against a Global Opponent

Index=alz-completesite

Athletes Personally Impacted by Alzheimer’s

Special Exhibitions

Index=alz-completesite

Museum Programs Inspire Those Facing Alzheimer’s

We Must Walk

Index=alz-completesite

The Equity in Neuroscience and Alzheimer’s Clinical Trials (ENACT) Act Introduced in Congress

Index=alz-completesite

Bipartisan Legislation to Support Equity in Alzheimer’s Clinical Trials Endorsed by Alzheimer’s Association, Alzheimer’s Impact Movement

News  |  Nebraska

500

Index=alz-pagecrawler

Journals

Index=alz-pagecrawler

Want to Help End Alzheimer’s? Enroll in a Clinical Trial

Index=alz-completesite

In the News | Future of Personal Health

Meet Our Donors

Index=alz-pagecrawler

Partnerships

Index=alz-pagecrawler

Make a Donation

Index=alz-pagecrawler

Blog

Index=alz-pagecrawler

Blog

Index=alz-pagecrawler

Zenith Society

Index=alz-pagecrawler

U.S. POINTER

Index=alz-pagecrawler

Our Brand

Index=alz-pagecrawler

Tribute Pages

Index=alz-pagecrawler

Research Funding

Index=alz-pagecrawler

Charity Miles

Index=alz-pagecrawler

Deluxe

Index=alz-pagecrawler

CARS

Index=alz-pagecrawler

Thank you

Index=alz-pagecrawler

FTD

Index=alz-pagecrawler

Esports Arena

Index=alz-pagecrawler

Clinical Challenges: Lifestyle and Alzheimer's Risk

Index=alz-completesite

In the News | MedPage Today

Mary Sano, Ph.D.

Index=alz-completesite

Clinical Trial Results at AAIC 2019 Focus on New Ideas and New Targets

Index=alz-completesite

Includes First Report of 18-Month Results From Phase 2/3 Trial of Inhaled Insulin in MCI and Alzheimer’s

FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease

Index=alz-completesite

FDA Advisory Committee unanimously endorsed the efficacy and clinical benefit of lecanemab as part of the traditional approval process for this treatment.

Alzheimer’s Association and Erb Family Foundation Establish Prestigious Clinical Research Science Fellowship

Index=alz-completesite

The Alzheimer’s Association appreciates the generosity of the Erb Family Foundation and its ongoing commitment to advance Alzheimer’s and dementia research

Training fellowship awarded to Alzheimer researcher

Index=alz-completesite

Alzheimer News 4/16/09 | Alzheimer's Association

Increased Risk of Subjective Cognitive Decline in the LGBT Community

Index=alz-completesite

Plus, First Clinical Intervention for LGBT People With Alzheimer’s and Caregivers

Next Steps for New Alzheimer's Treatment

Index=alz-completesite

As the global nonprofit leader in Alzheimer’s research and science we have extensively reviewed the clinical trial data for AduhelmTM (aducanumab).

Landmark U.S. POINTER Study Completes Recruitment of 2,000+ Participants, Including 30% from Underrepresented Communities

Index=alz-completesite

Leaders of the U.S. POINTER Study announced a historic milestone: recruiting for the clinical trial has been successfully completed.

Alzheimer’s Association Statement on Lecanemab Phase 3 Full Results

Index=alz-completesite

The Alzheimer’s Association welcomes and is further encouraged by the full Phase 3 data presented from the global Phase 3 clinical trial of lecanemab.

The Impact of COVID-19 and the Global Pandemic on Alzheimer’s Research, Long-Term Care and the Brain

Index=alz-completesite

The pandemic has caused significant disruption to all aspects of life — including Alzheimer’s clinical research worldwide — as well as unprecedented innovation.

C.A.R.E. Pharmacy Award winner announced

Index=alz-completesite

C.A.R.E. Pharmacy Award winner announced | Alzheimer's Association

First guidelines published for brain amyloid imaging in Alzheimer's

Index=alz-completesite

First guidelines published for brain amyloid imaging in Alzheimer’s | Alzheimer's Association

Alzheimer’s Association Calls on CMS to Reverse Its Decision to Severely Limit Access to FDA-Approved Alzheimer’s Disease Treatments

Index=alz-completesite

Association Files Formal Request for Reconsideration of National Coverage Determination

Alzheimer’s Association Launches ALZ-NET: A Long-Term Data Collection and Sharing Network for New Treatments

Index=alz-completesite

Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) collects long-term clinical & safety data from patients treated with FDA-approved therapies.

Alzheimer’s Association Announces New Grant Program to Support Real-World Data Platforms Globally

Index=alz-completesite

The Alzheimer's Association will award up to $5 million in funding to platforms outside the U.S. through the Global Real-World Data Platforms Program (ALZ-RWD).

Biogen’s Decision to Discontinue Alzheimer’s Drug

Index=alz-completesite

Despite Biogen's decision about discontinuing Aduhelm (aducanumab), the Alzheimer’s Association is optimistic about the future of Alzheimer’s treatments.

$47 Million Grant Adds Valuable Brain Imaging Measures to Large Alzheimer’s Clinical Trial of Lifestyle Intervention

Index=alz-completesite

The expanded study will be the first large-scale investigation of how lifestyle interventions affect Alzheimer’s and dementia in the brain.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association Announces New Deputy Editor

Index=alz-completesite

Lisa Barnes, Ph.D. is the new deputy editor of Alzheimer's & Dementia, the Alzheimer's Association's journal.

Alzheimer's Association statement on florbetapir PET amyloid imaging

Index=alz-completesite

Alzheimer's Association statement on florbetapir PET amyloid imaging | Alzheimer's Association

Alzheimer’s Association Welcomes U.S. FDA Approval of Lecanemab

Index=alz-completesite

Association Renews Urgent Call for CMS to Cover FDA-Approved Alzheimer’s Treatments

Advisory Council discusses significant recommendations for National Alzheimer's Plan

Index=alz-completesite

Alzheimer's News 01/18/12 | Alzheimer's Association

Alzheimer's Association Welcomes FDA Approval of Aducanumab

Index=alz-completesite

The Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease.

Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab

Index=alz-completesite

The Alzheimer's Association and members of the Early Stage Advisory Group urged the FDA to recommend traditional approval of Leqembi.

A Shared Hardship

Index=alz-completesite

Some Researchers Fight Alzheimer’s In and Out of the Lab

Founding Association member Katzman dies

Index=alz-completesite

Alzheimer News 9/29/2008 | Alzheimer's Association

Senate confirms new National Institutes of Health Director

Index=alz-completesite

Alzheimer News 8/10/2009 | Alzheimer's Association

Alzheimer's Association Statement on FDA Approval of Brexpiprazole

Index=alz-completesite

The Alzheimer’s Association welcomes the approval of brexpiprazole (Rexulti®), the first FDA-approved treatment to address dementia-related agitation.

CDC Selects Alzheimer’s Association as National Public Health Center of Excellence on Dementia Risk Reduction

Index=alz-completesite

Association one of three BOLD public health centers of excellence in the country

New Research Study to Demonstrate the Value of Brain PET Scans in Diagnosing Alzheimer’s in Diverse Populations

Index=alz-completesite

Alzheimer’s Association and American College of Radiology (ACR) announce recruiting for the New IDEAS Study

Congress Takes Action on Critical Alzheimer’s Legislation to Ensure Addressing Alzheimer’s Remains a National Priority and Continue Momentum on Research Funding

Index=alz-completesite

Today, the Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support the introduction of two bipartisan bills

New Alzheimer’s Association Report Reveals Top Stressors for Caregivers and Lack of Care Navigation Support and Resources

Index=alz-completesite

The 2024 Facts & Figures report also shows the latest national & state-by-state statistics on Alzheimer’s disease prevalence, mortality, costs & more.

Unforgettable

Index=alz-completesite

"Unforgettable," a family drama that tells the story of a Black and Hispanic family facing Alzheimer's, is touring the country in 2024.

Alzheimer's advisory council discusses initial draft of National Alzheimer's Plan

Index=alz-completesite

Alzheimer's News 3/15/2012 | Alzheimer's Association

Alzheimer's Association statement on FDA approval of florbetapir (Amyvid)

Index=alz-completesite

Alzheimer's News 4/6/2012 | Alzheimer's Association

$425 Million Increase in Alzheimer's Research Funding Passes U.S. Senate

Index=alz-completesite

Alzheimer’s Association, Alzheimer’s Impact Movement Request Approved by Full Senate

Alzheimer’s Association Offers Guidance to Long-Term and Community-Based Care Settings to Ensure High-Quality Dementia Care Continues During COVID-19 Crisis

Index=alz-completesite

Document outlines evidence-based strategies to address key care concerns. More than 30 long-term and community-based care provider groups supporting effort.

Senate Appropriators Reaffirm Commitment in Fight to End Alzheimer's

Index=alz-completesite

$354 million Alzheimer’s and dementia research funding increase proposed

Alzheimer's Association Partners with National Hispanic Medical Association to Increase Alzheimer's Awareness in Latino Communities

Index=alz-completesite

The Alzheimer’s Association and the National Hispanic Medical Association (NHMA) are partnering to increase concern and awareness of Alzheimer’s disease and all

Alzheimer’s Association Launches New Training and Certification Program to Enhance Dementia Care

Index=alz-completesite

Training and exam are aimed at implementing latest evidenced-based practices to ensure quality dementia care for a growing number of Americans

Food for Thought

Index=alz-completesite

Evidence Shows These Three Healthy Diets Can Benefit the Brain

Prevention on the Horizon?

Index=alz-completesite

What Can We Do to Prevent Alzheimer’s? This Question Has Been Asked by Concerned Individuals, Researchers for Years

Submit Study

Index=alz-pagecrawler

404

Index=alz-pagecrawler

China ADNI

Index=alz-pagecrawler

Korea ADNI

Index=alz-pagecrawler

Argentina ADNI

Index=alz-pagecrawler

Taiwan ADNI

Index=alz-pagecrawler

About This Site

Index=alz-pagecrawler

Sigma Alpha Mu

Index=alz-pagecrawler

Online Community

Index=alz-pagecrawler

U.S. Pointer

Index=alz-pagecrawler

Treatments

Index=alz-pagecrawler

Joel Berman

Index=alz-pagecrawler

Tenny Tsai

Index=alz-pagecrawler

Message Received

Index=alz-pagecrawler

Brain Tour

Index=alz-pagecrawler

Planned Giving

Index=alz-pagecrawler

Japan ADNI

Index=alz-pagecrawler

Alzheimer's Association Launches Pilot Program to Connect Dementia Care Experts With Assisted-Living Communities

Index=alz-completesite

ECHO Model to Emphasize High-Quality, Person-Centered Care in Long-Term, Community-Based Care Settings

Global Brain Health Leader Awards to Develop Dementia-Related Projects

Index=alz-completesite

To address the growing public health crisis of dementia, three leading organizations announced funding for 23 small-scale pilot projects

Alzheimer's Association, National Academy of Neuropsychology Fund Research Exploring COVID-19's Impact on the Brain in Diverse Populations

Index=alz-completesite

The Alzheimer’s Association and the National Academy of Neuropsychology (NAN) have awarded $800,000 in grants to researchers focusing on the impact of COVID-19

Scientific Conference on Dementia in Low- and Middle-Income Countries to be Held in Kenya

Index=alz-completesite

Dementia researchers at all career stages will gather Dec. 6-9 in Nairobi, Kenya at Dementia and Brain Aging in Low- and Middle-Income Countries (LMICs)

Critical Legislation to Renew National Commitment to Fighting Alzheimer’s Reintroduced in Congress

Index=alz-completesite

The Alzheimer’s Association and AIM are proud to support the reintroduction of the NAPA Reauthorization Act and the Alzheimer’s Accountability & Investment Act.

Alzheimer’s Advocates Turn House Budget Hearings Purple, Building Bipartisan Momentum for Access to FDA-Approved Alzheimer’s Treatments

Index=alz-completesite

The Alzheimer’s Association and bipartisan advocates urged the HHS secretary to cover FDA-approved Alzheimer’s treatments in this week's House budget hearings.

Hispanic Americans More Likely to Develop Dementia. Why?

Index=alz-completesite

Researchers Are Zeroing in on Promising Theories

Different Faiths, Same Fight

Index=alz-completesite

Communities of Faith Spread the Word About Dementia

Higher Ed, Lower Risk

Index=alz-completesite

Studies Link Formal Education to Reduced Risk of Alzheimer's

Put to the Test

Index=alz-completesite

What Your Genes Can and Can’t Tell You

A Mental Workout

Index=alz-completesite

Exercise May Lower Risk for Cognitive Decline

Bed Medicine

Index=alz-completesite

Research Shows the Brain Benefits from Good Sleep

Keep Your Brain Top of Mind During an Annual Checkup

Index=alz-completesite

Why You Should Get a Cognitive Assessment, and What to Expect

Medicare to Improve Dementia Care for Individuals Living with Alzheimer’s Disease, Caregivers

Index=alz-completesite

The Alzheimer's Association enthusiastically welcomes the announcement of a new CMS initiative to improve the way dementia care is delivered.

Alzheimer’s Association Announces New Dementia Care Navigation Roundtable

Index=alz-completesite

The roundtable will convene experts across the healthcare industry to establish consistent processes and protocols for dementia care navigation.

Alzheimer’s Association® Convenes the Tau2024 Global Conference, March 25-26, 2024

Index=alz-completesite

Leading tau experts from academia, industry and government will meet in Washington, D.C., and online to discuss this essential aspect of dementia research.

New study shows cognitive and social activity in midlife may reduce dementia risk in men

Index=alz-completesite

Alzheimer News 9/22/2008 | Alzheimer's Association

New Alzheimer's Association Report Shows Significant Disconnect Between Seniors, Physicians When It Comes to Cognitive Assessment

Index=alz-completesite

Report Provides Latest Alzheimer’s Prevalence, Incidence, Mortality and Costs of Care Data

Healthy Brain Initiative Continues Public Health Momentum By Kicking Off Next Road Map Development

Index=alz-completesite

An important effort to help state and local health departments address brain health across the life course.

Up-And-Coming Neuroscientists and Mentors Honored at Alzheimer’s Association International Conference Neuroscience Next

Index=alz-completesite

The Alzheimer’s Association recognized six pioneers in neuroscience research and mentorship at the third AAIC® Neuroscience Next conference.

Brain Donation: the ‘Greatest Gift to Science’

Index=alz-completesite

Brain Donation Helps Researchers Continue the Fight Against Alzheimer’s

Alzheimer’s Association Honors and Empowers Caregivers During National Family Caregivers Month and National Alzheimer’s Disease Awareness Month

Index=alz-completesite

New PSAs from Ad Council and Alzheimer’s Association Remind Families to Discuss Cognition Concerns Early

Karen Bell, M.D.

Index=alz-pagecrawler

Finances

Index=alz-pagecrawler

Donor Spotlight

Index=alz-pagecrawler

Search

Index=alz-pagecrawler

Virtual Library

Index=alz-pagecrawler

Governance

Index=alz-pagecrawler

Make a Donation

Index=alz-pagecrawler

Tribute Pages

Index=alz-pagecrawler

Aspire Society

Index=alz-pagecrawler

Alois Society

Index=alz-pagecrawler

OnStar

Index=alz-pagecrawler

Liz Adams

Index=alz-pagecrawler

State Overview

Index=alz-pagecrawler

Thank You

Index=alz-pagecrawler

Carewell

Index=alz-pagecrawler

Cutco

Index=alz-pagecrawler

Donate Stock

Index=alz-pagecrawler

Aspire Society

Index=alz-pagecrawler

Statements

Index=alz-pagecrawler

Goodcents

Index=alz-pagecrawler

AM Alz Page

Index=alz-pagecrawler

Caregiving

Index=alz-pagecrawler

Helpline

Index=alz-pagecrawler

Giving Societies

Index=alz-pagecrawler

Michael Reich

Index=alz-pagecrawler

Procter & Gamble

Index=alz-pagecrawler

Salon Series

Index=alz-pagecrawler

Donor Spotlight

Index=alz-pagecrawler

Sigma Alpha Mu

Index=alz-pagecrawler

Still Alice

Index=alz-pagecrawler

Monica Moreno

Index=alz-pagecrawler

Barbara Pryor

Index=alz-pagecrawler

eBay

Index=alz-pagecrawler

StarCorp

Index=alz-pagecrawler

Crayola Flowers

Index=alz-pagecrawler

MantraBand

Index=alz-pagecrawler

Edward Jones

Index=alz-pagecrawler

Bankers Life

Index=alz-pagecrawler

Publications

Index=alz-pagecrawler

Fan Fan, M.D.

Index=alz-pagecrawler

Hui Zheng, Ph.D.

Index=alz-pagecrawler

Donald Plaus

Index=alz-pagecrawler

Tony Gonzales

Index=alz-pagecrawler

Linc-AD

Index=alz-pagecrawler

Get Educated

Index=alz-pagecrawler

Art and Music

Index=alz-pagecrawler

Gina Adelman

Index=alz-pagecrawler

Founders Society

Index=alz-pagecrawler

Mixed Dementia

Index=alz-pagecrawler

Brain Donation

Index=alz-pagecrawler

Sue Sawyer

Index=alz-pagecrawler

Lori A. Jacobson

Index=alz-pagecrawler

Fred Bernhardt

Index=alz-pagecrawler

Paying for Care

Index=alz-pagecrawler

Home Safety

Index=alz-pagecrawler

Traveling

Index=alz-pagecrawler

Past Leadership

Index=alz-pagecrawler

Favorite Links

Index=alz-pagecrawler

New IDEAS Study

Index=alz-pagecrawler

Spring 2019

Index=alz-pagecrawler

Search Databases

Index=alz-pagecrawler

Guidelines Index

Index=alz-pagecrawler

Why Get Checked?

Index=alz-pagecrawler

Australia ADNI

Index=alz-pagecrawler

About WW-ADNI

Index=alz-pagecrawler

WW-ADNI Meetings

Index=alz-pagecrawler

Home

Index=alz-pagecrawler

European ADNI

Index=alz-pagecrawler

Summer 2019

Index=alz-pagecrawler

Glossary

Index=alz-pagecrawler

Dental Care

Index=alz-pagecrawler

Daily Care Plan

Index=alz-pagecrawler

Summer 2017

Index=alz-pagecrawler

Fall 2016

Index=alz-pagecrawler

Reducing Stress

Index=alz-pagecrawler

50 Activities

Index=alz-pagecrawler

For Teens

Index=alz-pagecrawler

Abuse

Index=alz-pagecrawler

Spring 2018

Index=alz-pagecrawler

Winter 2018

Index=alz-pagecrawler

Fall 2017

Index=alz-pagecrawler

Winter 2017

Index=alz-pagecrawler

Spring 2017

Index=alz-pagecrawler

Summer 2018

Index=alz-pagecrawler

Fall 2018

Index=alz-pagecrawler

Winter 2019

Index=alz-pagecrawler

NIA-AA Symposium

Index=alz-pagecrawler

Brain Facts

Index=alz-pagecrawler

For Kids

Index=alz-pagecrawler

Insurance

Index=alz-pagecrawler

Annual Report

Index=alz-pagecrawler

Use of Funds

Index=alz-pagecrawler

Use of Funds

Index=alz-pagecrawler

Resource Lists

Index=alz-pagecrawler

Why We Advocate

Index=alz-pagecrawler

Myths

Index=alz-pagecrawler

Elizabeth Shih

Index=alz-pagecrawler

Mail Preferences

Index=alz-pagecrawler

First Responders

Index=alz-pagecrawler

Event Search

Index=alz-pagecrawler

About

Index=alz-pagecrawler

About

Index=alz-pagecrawler

Helpline

Index=alz-pagecrawler

Press Resources

Index=alz-pagecrawler

Workplace Giving

Index=alz-pagecrawler

Donate a Vehicle

Index=alz-pagecrawler

Puerto Rico

Index=alz-pagecrawler

Mark Leon

Index=alz-pagecrawler

Health Equity

Index=alz-pagecrawler

Advocacy

Index=alz-pagecrawler

A Family Affair

Index=alz-pagecrawler

NADAM

Index=alz-pagecrawler

The Judy Fund

Index=alz-pagecrawler

Robert Egge

Index=alz-pagecrawler

Donna McCullough

Index=alz-pagecrawler

Alex Tsao, Ph.D.

Index=alz-pagecrawler

Bret Hill

Index=alz-pagecrawler

Bruce Baude

Index=alz-pagecrawler

Chuck Garrett

Index=alz-pagecrawler

Dean Brenner

Index=alz-pagecrawler

Geoff Heredia

Index=alz-pagecrawler

George Walz

Index=alz-pagecrawler

Joe Arciniega

Index=alz-pagecrawler

Karyne Jones

Index=alz-pagecrawler

Nancy Westcott

Index=alz-pagecrawler

Nicole Walker

Index=alz-pagecrawler

Rushern Baker

Index=alz-pagecrawler

Sarah Lorance

Index=alz-pagecrawler

Wendy Drummond

Index=alz-pagecrawler

William Thomas

Index=alz-pagecrawler

About Our Grants

Index=alz-pagecrawler

First Survivor

Index=alz-pagecrawler

HearingLife

Index=alz-pagecrawler

Alois Society

Index=alz-pagecrawler

Marshalls

Index=alz-pagecrawler

Improving Care

Index=alz-pagecrawler

Faribault Mill

Index=alz-pagecrawler

Sam Fazio, Ph.D.

Index=alz-pagecrawler

Support Groups

Index=alz-pagecrawler

Hospice Care

Index=alz-pagecrawler

Respite Care

Index=alz-pagecrawler

Repetition

Index=alz-pagecrawler

Hallucinations

Index=alz-pagecrawler

Mikaela Louie

Index=alz-pagecrawler

Medicaid

Index=alz-pagecrawler

Lokai

Index=alz-pagecrawler

Alaska

Index=alz-pagecrawler

Arkansas

Index=alz-pagecrawler

Colorado

Index=alz-pagecrawler

Connecticut

Index=alz-pagecrawler

Delaware

Index=alz-pagecrawler

Florida

Index=alz-pagecrawler

Idaho

Index=alz-pagecrawler

Illinois

Index=alz-pagecrawler

Indiana

Index=alz-pagecrawler

Maine

Index=alz-pagecrawler

Massachusetts

Index=alz-pagecrawler

Michigan

Index=alz-pagecrawler

Mississippi

Index=alz-pagecrawler

Montana

Index=alz-pagecrawler

Nebraska

Index=alz-pagecrawler

Nevada

Index=alz-pagecrawler

North Carolina

Index=alz-pagecrawler

North Dakota

Index=alz-pagecrawler

Ohio

Index=alz-pagecrawler

Oklahoma

Index=alz-pagecrawler

Pennsylvania

Index=alz-pagecrawler

South Dakota

Index=alz-pagecrawler

Vermont

Index=alz-pagecrawler

Virginia

Index=alz-pagecrawler

West Virginia

Index=alz-pagecrawler

Wyoming

Index=alz-pagecrawler

Washington, D.C.

Index=alz-pagecrawler

Alabama

Index=alz-pagecrawler

Iowa

Index=alz-pagecrawler

Kentucky

Index=alz-pagecrawler

New Hampshire

Index=alz-pagecrawler

E-News Archives

Index=alz-pagecrawler

Online Tools

Index=alz-pagecrawler

ALZNavigator™

Index=alz-pagecrawler

NARFE News

Index=alz-pagecrawler

Katie Evans

Index=alz-pagecrawler

Spokespeople

Index=alz-pagecrawler

Any Given Moment

Index=alz-pagecrawler

Just Diagnosed

Index=alz-pagecrawler

Publications

Index=alz-pagecrawler

Legal Planning

Index=alz-pagecrawler

Legal Documents

Index=alz-pagecrawler

Bathing

Index=alz-pagecrawler

Activities

Index=alz-pagecrawler

Food and Eating

Index=alz-pagecrawler

Incontinence

Index=alz-pagecrawler

Medicare

Index=alz-pagecrawler

Quality of Care

Index=alz-pagecrawler

Technology 101

Index=alz-pagecrawler

Research

Index=alz-pagecrawler

California

Index=alz-pagecrawler

Milestones

Index=alz-pagecrawler

Strategic Plan

Index=alz-pagecrawler

Our Impact

Index=alz-pagecrawler

How to Apply

Index=alz-pagecrawler

Georgia

Index=alz-pagecrawler

Looking Inward

Index=alz-pagecrawler

#ENDALZ Athletes

Index=alz-pagecrawler

Long-Term Care

Index=alz-pagecrawler

In-Home Care

Index=alz-pagecrawler

Depression

Index=alz-pagecrawler

Caregiver Stress

Index=alz-pagecrawler

Arizona

Index=alz-pagecrawler

Kansas

Index=alz-pagecrawler

Louisiana

Index=alz-pagecrawler

Minnesota

Index=alz-pagecrawler

New Jersey

Index=alz-pagecrawler

New York

Index=alz-pagecrawler

New Mexico

Index=alz-pagecrawler

Oregon

Index=alz-pagecrawler

Rhode Island

Index=alz-pagecrawler

Texas

Index=alz-pagecrawler

Utah

Index=alz-pagecrawler

Wisconsin

Index=alz-pagecrawler

Hawaii

Index=alz-pagecrawler

Maryland

Index=alz-pagecrawler

Missouri

Index=alz-pagecrawler

South Carolina

Index=alz-pagecrawler

Tennessee

Index=alz-pagecrawler

Washington

Index=alz-pagecrawler

Keep Up With Alzheimer’s News and Events

The first survivor of Alzheimer's is out there, but we won't get there without you.

Donate Now

Learn how Alzheimer’s disease affects the brain.

Take the Brain Tour

Don't just hope for a cure. Help us find one. Volunteer for a
clinical trial.

Learn More